Biggest News Aggregation in the World
📰 Alligator Bioscience News

Page 2 - Alligator Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alligator Bioscience. Real-time updates on events, politics, business and more.

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial

Trial to Evaluate Safety, Tolerability and Clinical Activity in Solid Tumors Expressing 5T4LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / February 13, 2023 / Alligator Bioscience AB ("Alligator") (Nasdaq
United States Miriam Weber Miller Aptevo Therapeuticsview Guillaume Van Renterghem Marvin White Exchange Commission

Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued a May Proceed Notification for the ALG.APV-527 IND

Drug Candidate progressing to the clinic for evaluation in the treatment of 5T4-expressing tumor antigens in multiple solid tumor typesLUND, SWEDEN and SEATTLE WA / ACCESSWIRE / September 19, 2022 / Alligator
Miriam Weber Miller Guillaume Van Renterghem Marvin White Society Of Immunotherapy Cancer Aptevo Therapeutics Inc Macrogenics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Financial Comparison: Aptevo Therapeutics (NASDAQ:APVO) & Histogen (NASDAQ:HSTO)

Aptevo Therapeutics (NASDAQ:APVO – Get Rating) and Histogen (NASDAQ:HSTO – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Profitability This table compares Aptevo Therapeutics and Histogen’s net margins, […]
United States San Diego Aptevo Therapeutics Company Profile Get Rating Aptevo Therapeutics Inc Histogen Company Profile Get Rating Histogen Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science